Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shubin Lai"'
Autor:
Meiyue Li, Shen Lin, Leslie Wilson, Pinfang Huang, Hang Wang, Shubin Lai, Liangliang Dong, Xiongwei Xu, Xiuhua Weng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundHepatic arterial infusion (HAI) of oxaliplatin, leucovorin, and fluorouracil (FOLFOX) plus sorafenib has a more desirable effect versus sorafenib for hepatocellular carcinoma (HCC) patients with portal vein invasion. However, considering th
Externí odkaz:
https://doaj.org/article/3f6e479d155b4fd3a8f5077ccf621134
Autor:
Dayong Zeng, Xin Rao, Shaohong Luo, Xiuhua Weng, Pinfang Huang, Shubin Lai, Lixian Zhong, Shen Lin
Publikováno v:
International journal of clinical pharmacy. 42(4)
Background Adding atezolizumab to carboplatin/nab-paclitaxel improved progression-free survival and overall survival in patients with advanced non-squamous non-small-cell lung cancer. However, estimating the economy of atezolizumab/carboplatin/nab-pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f984d16f0cdd74259b31f7e9c3e43110
https://pubmed.ncbi.nlm.nih.gov/32524512
https://pubmed.ncbi.nlm.nih.gov/32524512